Our data when viewed in conjunction with previous studies on tumor-infiltrating CD8+CD103+ T cells suggest that, depending on the cancer type, CD8+CD103+ TRMs can either promote or inhibit the development of metastasis in cancer. The gene discussed is CD8A; the disease is neoplasm.